Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Nov-Dec;55(6):460-2.
doi: 10.4103/0301-4738.36484.

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye

A Raghuram  1 , V R Saravanan, V Narendran
Affiliations
Case Reports

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye

A Raghuram et al. Indian J Ophthalmol. 2007 Nov-Dec.

Abstract

Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months of follow-up.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Slit-lamp photograph showing circumcorneal congestion and neovascularization over the iris and lens capsule (Black arrow); (B and C) Photographs showing the total regression of neovascularization one week and six months respectively following intracameral injection of bevacizumab (Avastin)
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

References

    1. Rosenfeld PJ, Moshfegh AA, Puliafito CA. Optical Coherence Tomography findings after intravitreal injection of bevacizumab (Avastin) for neovascular age related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331–5. - PubMed
    1. Avery RL, Pieramjci DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363–72. - PubMed
    1. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275–8. - PubMed
    1. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 2006;26:352–4. - PubMed
    1. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 2006;26:354–6. - PubMed

Publication types

MeSH terms

Substances